MX352647B - Metodo para temporizar una colonoscopia en donde se administra una composicion de picosulfato. - Google Patents
Metodo para temporizar una colonoscopia en donde se administra una composicion de picosulfato.Info
- Publication number
- MX352647B MX352647B MX2014000593A MX2014000593A MX352647B MX 352647 B MX352647 B MX 352647B MX 2014000593 A MX2014000593 A MX 2014000593A MX 2014000593 A MX2014000593 A MX 2014000593A MX 352647 B MX352647 B MX 352647B
- Authority
- MX
- Mexico
- Prior art keywords
- colonoscopy
- composition
- timing
- picosulate
- administered
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 238000002052 colonoscopy Methods 0.000 title abstract 3
- UJIDKYTZIQTXPM-UHFFFAOYSA-N [4-[pyridin-2-yl-(4-sulfooxyphenyl)methyl]phenyl] hydrogen sulfate Chemical compound C1=CC(OS(=O)(=O)O)=CC=C1C(C=1N=CC=CC=1)C1=CC=C(OS(O)(=O)=O)C=C1 UJIDKYTZIQTXPM-UHFFFAOYSA-N 0.000 abstract 2
- 230000037406 food intake Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
Con base en la presente descripción, un intervalo de tiempo mínimo se puede lograr entre la última ingestión de una composición de picosulfato y la realización de la colonoscopía. Por ejemplo, la presente descripción se dirige a un método para temporizar un procedimiento de colonoscopía realizado en un paciente necesitado del mismo, que comprende: administrar, al paciente, un equipo de composición intestinal de picosulfato de acuerdo con las instrucciones del equipo; realizar el procedimiento menos de aproximadamente 4 horas después de la administración del equipo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161508189P | 2011-07-15 | 2011-07-15 | |
| PCT/US2012/046874 WO2013012783A1 (en) | 2011-07-15 | 2012-07-16 | Method for timing a colonoscopy wherein a picosulate composition is administered |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2014000593A MX2014000593A (es) | 2014-07-30 |
| MX352647B true MX352647B (es) | 2017-12-04 |
Family
ID=46642617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014000593A MX352647B (es) | 2011-07-15 | 2012-07-16 | Metodo para temporizar una colonoscopia en donde se administra una composicion de picosulfato. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9669110B2 (es) |
| EP (2) | EP3269368A1 (es) |
| JP (2) | JP6376975B2 (es) |
| KR (1) | KR20140063602A (es) |
| CN (1) | CN103841970A (es) |
| AU (1) | AU2012284200B2 (es) |
| BR (1) | BR112014000843A8 (es) |
| CA (1) | CA2841751A1 (es) |
| DK (1) | DK2731607T3 (es) |
| ES (1) | ES2655172T3 (es) |
| HU (1) | HUE034895T2 (es) |
| MX (1) | MX352647B (es) |
| NO (1) | NO2731607T3 (es) |
| PL (1) | PL2731607T3 (es) |
| WO (1) | WO2013012783A1 (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0117057D0 (en) * | 2001-07-12 | 2001-09-05 | Ferring Bv | Pharmaceutical composition |
| TWI442932B (zh) | 2008-02-11 | 2014-07-01 | Ferring Int Ct Sa | 以ＧｎＲＨ拮抗劑治療攝護腺癌的方法 |
| CN105663059A (zh) * | 2009-05-01 | 2016-06-15 | 辉凌公司 | 用于治疗前列腺癌的组合物 |
| US20110039787A1 (en) * | 2009-07-06 | 2011-02-17 | Ferring International Center S.A. | Compositions, kits and methods for treating benign prostate hyperplasia |
| EP2447276A1 (en) | 2010-10-27 | 2012-05-02 | Ferring B.V. | Process for the manufacture of Degarelix and its intermediates |
| PT2632934T (pt) | 2010-10-27 | 2017-01-06 | Ferring Bv | Processo para o fabrico de degarelix e seus intermediários |
| JO3755B1 (ar) | 2011-01-26 | 2021-01-31 | Ferring Bv | تركيبات تستوستيرون |
| PL4512390T1 (pl) | 2012-06-01 | 2025-09-01 | Ferring B.V. | Wytwarzanie degareliksu |
| CN103405395B (zh) * | 2013-08-23 | 2015-04-22 | 山东省医药工业研究所 | 匹可硫酸钠肠溶片及其制备方法 |
| KR101420315B1 (ko) | 2014-03-19 | 2014-07-17 | 남봉길 | 약학적 액제 조성물 |
| JP2018523694A (ja) * | 2015-08-17 | 2018-08-23 | フェリング ベスローテン フェンノートシャップ | ピコスルファートおよびクエン酸マグネシウムを含む液体製剤 |
| CN105456264B (zh) * | 2015-12-03 | 2018-07-10 | 广州瑞尔医药科技有限公司 | 双效缓泻的药物组合物及其制备方法 |
| TW201804996A (zh) | 2016-07-08 | 2018-02-16 | 輝凌責任有限公司 | 含有匹可硫酸鹽(picosulfate)之安定液體調配物 |
| GB2559405A (en) * | 2017-02-06 | 2018-08-08 | Owlstone Med Ltd | Improvements in or relating to preparation of subjects for medical or veterinary examination |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009140764A1 (en) * | 2008-05-23 | 2009-11-26 | Kingston General Hospital | Colon cleansing method and kit |
| US20140087007A1 (en) | 2012-09-27 | 2014-03-27 | Braintree Laboratories, Inc. | Bowel cleansing preparations |
-
2012
- 2012-07-16 US US13/549,889 patent/US9669110B2/en active Active
- 2012-07-16 WO PCT/US2012/046874 patent/WO2013012783A1/en not_active Ceased
- 2012-07-16 MX MX2014000593A patent/MX352647B/es active IP Right Grant
- 2012-07-16 NO NO12745940A patent/NO2731607T3/no unknown
- 2012-07-16 JP JP2014521688A patent/JP6376975B2/ja active Active
- 2012-07-16 ES ES12745940.2T patent/ES2655172T3/es active Active
- 2012-07-16 EP EP17177814.5A patent/EP3269368A1/en not_active Withdrawn
- 2012-07-16 AU AU2012284200A patent/AU2012284200B2/en active Active
- 2012-07-16 BR BR112014000843A patent/BR112014000843A8/pt not_active Application Discontinuation
- 2012-07-16 CN CN201280042345.2A patent/CN103841970A/zh active Pending
- 2012-07-16 EP EP12745940.2A patent/EP2731607B1/en active Active
- 2012-07-16 KR KR1020147003785A patent/KR20140063602A/ko not_active Ceased
- 2012-07-16 CA CA2841751A patent/CA2841751A1/en not_active Abandoned
- 2012-07-16 HU HUE12745940A patent/HUE034895T2/hu unknown
- 2012-07-16 PL PL12745940T patent/PL2731607T3/pl unknown
- 2012-07-16 DK DK12745940.2T patent/DK2731607T3/en active
-
2016
- 2016-12-09 JP JP2016238984A patent/JP2017061560A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NO2731607T3 (es) | 2018-03-10 |
| EP3269368A1 (en) | 2018-01-17 |
| US20130018223A1 (en) | 2013-01-17 |
| JP6376975B2 (ja) | 2018-08-22 |
| EP2731607A1 (en) | 2014-05-21 |
| AU2012284200B2 (en) | 2016-09-22 |
| BR112014000843A8 (pt) | 2017-10-10 |
| KR20140063602A (ko) | 2014-05-27 |
| CA2841751A1 (en) | 2013-01-24 |
| WO2013012783A1 (en) | 2013-01-24 |
| DK2731607T3 (en) | 2018-01-02 |
| ES2655172T3 (es) | 2018-02-19 |
| AU2012284200A1 (en) | 2014-02-06 |
| EP2731607B1 (en) | 2017-10-11 |
| JP2017061560A (ja) | 2017-03-30 |
| HUE034895T2 (hu) | 2018-03-28 |
| JP2014520884A (ja) | 2014-08-25 |
| BR112014000843A2 (pt) | 2017-08-22 |
| MX2014000593A (es) | 2014-07-30 |
| CN103841970A (zh) | 2014-06-04 |
| US9669110B2 (en) | 2017-06-06 |
| PL2731607T3 (pl) | 2018-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX352647B (es) | Metodo para temporizar una colonoscopia en donde se administra una composicion de picosulfato. | |
| SG179027A1 (en) | Dosage regimen for administering an epcamxcd3 bispecific antibody | |
| PH12014501133A1 (en) | Compositions and methods for treating hepatitis c virus | |
| MX2013006846A (es) | Inhibidores de la replicacion de los virus de la influenza. | |
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| PH12015501678A1 (en) | Inhibitors of influenza viruses replication | |
| PH12014500257A1 (en) | Inhibitors of influenza viruses replication | |
| WO2012083122A8 (en) | Inhibitors of influenza viruses replication | |
| MY171317A (en) | Orally administered corticosteroid compositions | |
| EP2512479A4 (en) | METHOD AND COMPOSITIONS FOR TREATING PERIPHERAL VASCULAR DISEASE | |
| NZ619076A (en) | Isoxazolines as inhibitors of fatty acid amide hydrolase | |
| MY173215A (en) | Acetylcysteine compositions and methods of use thereof | |
| MX336347B (es) | Metodo para atenuar los efectos adversos del farmaco usando los acidos grasos omega-3 como un vehiculo terapeutico parenteral del farmaco. | |
| NZ734152A (en) | Compounds, compositions and methods useful for cholesterol mobilisation | |
| MX2011009709A (es) | Compuestos para el tratamiento de la inflamacion y del dolor. | |
| WO2013028818A8 (en) | Pyrimido- pyridazinone compounds and use thereof | |
| WO2009155070A3 (en) | Compositions and methods for treatment of inflammation and hyperkeratotic lesions | |
| MX337593B (es) | Gemcabeno y derivados para tratar la pancreatitis. | |
| WO2011133479A3 (en) | Combination therapy with a proteasome inhibitor and a gallium complex | |
| RU2013148539A (ru) | Алиспоривир для лечения инфекции вируса гепатита с | |
| RU2011108787A (ru) | Способ лечения больных красным плоским лишаем слизистой полости рта | |
| UA58749U (ru) | Способ лечения стеатоза печени у больных туберкулезом | |
| UA64808U (ru) | Способ фармакокорекции синдрома эндогенной интоксикации, возникающего в постдекомпрессионном периоде краш-синдрома | |
| PH22011000655U1 (en) | Pharmaceutical herbal composition | |
| UA58754U (ru) | Способ медицинской реабилитации больных неалкогольным стеатогепатитом на фоне сахарного диабета 2-го типа |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |